Shadman, M., Brown, J. R., Williams, R., Mohseninejad, L., Yang, K., Rakonczai, P., . . . Tam, C. S. (2025). Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): A matching-adjusted indirect comparison (MAIC). SAGE Publishing.
Chicago Style (17th ed.) CitationShadman, Mazyar, et al. Efficacy of Zanubrutinib Versus Acalabrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL): A Matching-adjusted Indirect Comparison (MAIC). SAGE Publishing, 2025.
MLA (9th ed.) CitationShadman, Mazyar, et al. Efficacy of Zanubrutinib Versus Acalabrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL): A Matching-adjusted Indirect Comparison (MAIC). SAGE Publishing, 2025.
Warning: These citations may not always be 100% accurate.